Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer

Withdrawn before enrolling · Not applicable

Conditions studied: Colorectal Cancer

In brief

The purpose of this study is to determine the diagnostic accuracy of ferumoxytol-enhanced MRI in detecting lymph nodes that have been invaded by tumor cells in patients with colorectal cancer.

Key facts

Study ID

NCT01983371

Run by

Scott Potenta, MD, PhD

People needed

0

Starts

2013-12-01

Expected to finish

2016-06-01

Last updated by the study team

2016-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years of age or older with histologically confirmed colorectal cancer
• Planned for surgical resection of tumor

You may not qualify if…

• Contraindications for MRI
• Contraindication or known allergy to ferumoxytol or parental iron products (e.g. iron sucrose, iron dextran, etc.)
• Planned chemotherapy or radiation treatment prior to surgical resection of primary tumor
• Uncontrolled serious medical illness
• Unable or unwilling to give informed consent
• Pregnancy
• Breastfeeding women
• Clinically documented or known risk of primary or secondary iron overloading including history of thalassemia, sickle cell anemia, hereditary hemochromatosis or first-degree relative with known hemochromatosis, multiple transfusions for any reason within the past 5 years, or use of over-the-counter ferrous sulfate without the supervision of his/her doctor

Where it is running

• University of Vermont Medical Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.